AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Apr 28, 2011
30016_dirs_2011-04-28_aa584235-b3b0-4d96-bdd9-23fd1f81cd78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-04-26
Reporting Person: CRAIG THOMAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-26 | Common Stock | M | 7000 | $14.53 | Acquired | 16684 | Direct |
| 2011-04-26 | Common Stock | S | 7000 | $80.3290 | Disposed | 9684 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-26 | Non-Qualified Stock Option (right to buy) | $14.53 | M | 7000 | Disposed | 2012-05-15 | Common Stock (7000) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $80.3108 to $80.5300, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant (05/15/2003).
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26